Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer
Adam Kinnaird(University of Alberta), Leonard S. Marks(Urological Research Foundation), Barış Türkbey(National Institutes of Health), Maria J. Merino(National Institutes of Health), Bradford J. Wood(National Institutes of Health), Anthony Sisk(University of California, Los Angeles), Merdie Delfin(University of California, Los Angeles), Peter A. Pinto(National Institutes of Health), Ryan Chuang(University of California San Diego), Ely Felker(University of California, Los Angeles), Lorna Kwan(University of California, Los Angeles), Michael Daneshvar(University of California, Irvine), Nitin Yerram(National Institutes of Health), Danielle Barsa(University of California, Los Angeles), Wayne Brisbane(University of California, Los Angeles), Alan Priester(University of California, Los Angeles), Rajiv Jayadevan(University of California, Los Angeles), Peter L. Choyke(National Cancer Institute), Robert E. Reiter(University of California, Los Angeles), Michael Ahdoot(National Institutes of Health), Elizabeth Tran(University of California San Diego), Luke O’Connor(National Institutes of Health), Steve Raman(University of California, Los Angeles), Vidit Sharma(University of California, Los Angeles)
Cited by 8
Related Papers
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
|Nature Genetics|1997|1.5k
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Federated learning for predicting clinical outcomes in patients with COVID-19
|Nature Medicine|2021|760
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592